NOVARTIS AG-REG (1NOVN.MI) Earnings History & Surprises
BIT:1NOVN • CH0012005267
134 EUR
-7 (-4.96%)
Last: Mar 9, 2026, 07:00 PM
Past quarterly earnings results for NOVARTIS AG-REG (1NOVN.MI), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Release DateApr 27, 2026
PeriodQ1 / 2026
EPS Estimate$2.15
Revenue Estimate13.825B
Last Reported
Release DateFeb 4, 2026
PeriodQ4 / 2025
EPS Reported$2.03
EPS Surprise -0.17%
Revenue Surprise -4.89%
Beat Rate
63%
EPS and Revenuebeats vs estimates
Quarterly Earnings Results
EPS & Revenue History (USD)
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 2.03 | 2.03 | -0.17% | 2.53% | 13.336B | 14.022B | -4.89% | 1.39% |
| Q3 2025 | 2.25 | 2.30 | -2.10% | 9.22% | 13.909B | 14.312B | -2.82% | 5.60% |
| Q2 2025 | 2.42 | 2.41 | 0.61% | 22.84% | 14.054B | 14.465B | -2.84% | 9.18% |
| Q1 2025 | 2.28 | 2.14 | 6.59% | 26.67% | 13.233B | 13.384B | -1.13% | 9.18% |
| Q4 2024 | 1.98 | 1.87 | 6.06% | 29.41% | 13.153B | 13.051B | 0.78% | 11.69% |
| Q3 2024 | 2.06 | 1.99 | 3.78% | 12.57% | 13.172B | 12.994B | 1.37% | 8.93% |
| Q2 2024 | 1.97 | 1.91 | 3.24% | 7.65% | 12.872B | 12.61B | 2.08% | 9.60% |
| Q1 2024 | 1.80 | 1.71 | 5.40% | 5.26% | 12.12B | 11.709B | 3.51% | 9.71% |
| Q4 2023 | 1.53 | 1.65 | -7.44% | 0.66% | 11.776B | 11.996B | -1.83% | 8.24% |
| Q3 2023 | 1.83 | 1.76 | 3.88% | 15.82% | 12.092B | 12.001B | 0.76% | 12.14% |
| Q2 2023 | 1.83 | 1.73 | 5.73% | 17.31% | 11.745B | 13.518B | -13.12% | -45.91% |
| Q1 2023 | 1.71 | 1.56 | 9.32% | 17.12% | 11.047B | 12.877B | -14.21% | -14.64% |
| Q4 2022 | 1.52 | 1.43 | 6.28% | 8.57% | 10.88B | 13.285B | -18.10% | 135.55% |
| Q3 2022 | 1.58 | 1.58 | -0.02% | -7.60% | 10.783B | 13.106B | -17.72% | -19.33% |
| Q2 2022 | 1.56 | 1.53 | 2.08% | -6.02% | 21.712B | 13.109B | 65.63% | 63.32% |
| Q1 2022 | 1.46 | 1.47 | -0.62% | -3.95% | 12.942B | - | 1.95% | |
| Q4 2021 | 1.40 | 1.45 | -3.12% | 4.48% | 4.619B | 13.616B | -66.08% | -64.55% |
| Q3 2021 | 1.71 | 1.68 | 1.93% | 12.50% | 13.367B | 13.285B | 0.62% | 6.61% |
| Q2 2021 | 1.66 | 1.57 | 5.67% | 22.06% | 13.294B | 12.773B | 4.08% | 14.39% |
| Q1 2021 | 1.52 | 1.59 | -4.32% | -2.56% | 12.694B | 12.771B | -0.60% | -0.11% |
| Q4 2020 | 1.34 | 1.40 | -4.21% | - | 13.03B | 13.147B | -0.89% | - |
| Q3 2020 | 1.52 | 1.48 | 2.60% | - | 12.538B | 12.818B | -2.18% | - |
| Q2 2020 | 1.36 | 1.35 | 0.78% | - | 11.622B | 12.13B | -4.19% | - |
| Q1 2020 | 1.56 | 1.42 | 9.89% | - | 12.708B | 12.249B | 3.75% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
2
Average EPS beat (4)
1.23%
Max EPS beat (4)
6.59%
Min EPS beat (4)
-2.10%
Revenue beat statistics
Revenue beat (4)
0
Average Revenue beat (4)
-2.92%
Max Revenue beat (4)
-1.13%
Min Revenue beat (4)
-4.89%
Analysis
In the last 4 quarters, 1NOVN.MI has beaten EPS estimates in 2 out of 4 releases
1NOVN.MI has not beaten revenue estimates in any of the last 4 earnings releases
In the last 4 quarters, 1NOVN.MI has beaten the EPS estimates by 1.2% on average.
In the last 4 quarters, 1NOVN.MI reported -2.9% below the revenue estimates on average.
NOVARTIS AG-REG / 1NOVN.MI Earnings FAQ
When did NOVARTIS AG-REG (1NOVN.MI) report earnings last quarter?
NOVARTIS AG-REG (1NOVN.MI) last reported earnings on 2/4/2026.
Did 1NOVN stock beat earnings estimates in the most recent quarter?
NOVARTIS AG-REG (1NOVN.MI) missed EPS estimates and missed revenue estimates in the most recent quarter.
Can you provide information on how often NOVARTIS AG-REG beats earnings estimates?
In the last 4 quarters, NOVARTIS AG-REG (1NOVN.MI) has beaten EPS estimates in 2 out of 4 releases.